amyrin palmitate

amyrin palmitate Chemische Eigenschaften,Einsatz,Produktion Methoden

• Beschreibung

  Beta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity. Beta-Amyrin palmitate, like mianserin and imipramine, reduces the duration of immobility of mice significantly in a dose-dependent manner (5, 10 and 20 mg kg-1); (1)Beta-Amyrin palmitate or mianserin elicits a dose-related reduction in locomotor activity of mice and antagonizes locomotor stimulation induced by methamphetamine, imipramine increases locomotor activity and potentiates methamphetamine-induced hyperactivity; (2)Beta-Amyrin palmitate shows no effect on reserpine-induced hypothermia, whilst mianserin (10 mg kg-1) and imipramine (10 and 20 mg kg-1) antagonizes the reserpine-induced effect; (3)Beta-amyrin palmitate has similar properties in some respects to mianserin and might possess a sedative action.

• target

  LDL | HMG-CoA Reductase | Adrenergic Receptor

amyrin palmitate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(54)Suppliers

5973-06-8, amyrin palmitate Verwandte Suche: